Blood tests for tau, a key biomarker of Alzheimer’s disease, may predict dementia risk, a new study found. How best to use the test, however, is unclear.

A commercial assay that measures eMTBR-tau may be an alternative to tau PET imaging in diagnosing Alzheimer’s disease, according to data presented at the Alzheimer’s Association…

Older adults who were cognitively healthy but had very high levels of p-tau217 were 78% more likely to develop cognitive impairment within a decade, according to data presented at…